Serum antibodies against the hepatitis C virus E2 protein mediate antibody-dependent cellular cytotoxicity (ADCC). (Q42991296)

12 November 2017

title

Serum antibodies against the hepatitis C virus E2 protein mediate antibody-dependent cellular cytotoxicity (ADCC). (English)

1 reference

12 November 2017

1 reference

1 reference

9

Michael Houghton

1 reference

12 November 2017

1

Jacob Nattermann

1 reference

12 November 2017

10

Tilman Sauerbruch

1 reference

12 November 2017

11

Ulrich Spengler

1 reference

12 November 2017

author name string

Angelika Maria Schneiders

2

1 reference

12 November 2017

Ludger Leifeld

3

1 reference

12 November 2017

Bettina Langhans

4

1 reference

12 November 2017

Monika Schulz

5

1 reference

12 November 2017

Geneviève Inchauspé

6

1 reference

12 November 2017

Bertfried Matz

7

1 reference

12 November 2017

Hans H Brackmann

8

1 reference

12 November 2017

publication date

21 January 2005

1 reference

12 November 2017

published in

Journal of Hepatology

1 reference

12 November 2017

volume

42

1 reference

12 November 2017

issue

4

1 reference

12 November 2017

page(s)

499-504

1 reference

Binding of hepatitis C virus to CD81

12 November 2017

cites work

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.282.5390.938

A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2004.12.018

Antibody-dependent cellular cytotoxicity via humoral immune epitope of Nef protein expressed on cell surface

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2004.12.018

Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2004.12.018

Expression of unmodified hepatitis C virus envelope glycoprotein-coding sequences leads to cryptic intron excision and cell surface expression of E1/E2 heterodimers comprising full-length and partially deleted E1

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2004.12.018

The role of antibody concentration and avidity in antiviral protection.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2004.12.018

Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2004.12.018

Natural cytotoxicity and antibody-dependent cellular cytotoxicity (ADCC) is not impaired in patients suffering from chronic hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2004.12.018

A novel non-radioactive cellular cytotoxicity test based on the differential assessment of living and killed target and effector cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2004.12.018

Antibody-dependent cellular cytotoxicity independently predicts survival in severely immunocompromised human immunodeficiency virus-infected patients

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2004.12.018

Limited antibody-dependent cellular cytotoxicity antibody response induced by a herpes simplex virus type 2 subunit vaccine

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2004.12.018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2004.12.018

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2004.12.018

Antibody and antibody-dependent cellular cytotoxicity responses against the BamHI A rightward open-reading frame-1 protein of Epstein-Barr virus (EBV) in EBV-associated disorders

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2004.12.018

An immunoassay for specific amplified HCV sequences.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2004.12.018

Plasma membrane hydroxyethyl radical adducts cause antibody-dependent cytotoxicity in rat hepatocytes exposed to alcohol

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2004.12.018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2004.12.018

Comparison of measles virus-specific antibodies with antibody-dependent cellular cytotoxicity and neutralizing functions

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2004.12.018

Surprisingly small effect of antiviral treatment in patients with hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2004.12.018

Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JHEP.2004.12.018

Identifiers

DOI

10.1016/J.JHEP.2004.12.018

1 reference

12 November 2017

1 reference